Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
131.95
+0.20 (+0.15%)
Official Closing Price
Updated: 7:00 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
64
65
Next >
Merck's Best Selling Cancer Drug Meets One Goal In Late-Stage Bladder Cancer Study
October 05, 2023
Merck & Co Inc (NYSE: MRK) announced that the Phase 3 AMBASSADOR (A031501) trial (KEYNOTE-123) evaluating Keytruda met one of its dual primary endpoints of disease-free survival for the adjuvant...
Via
Benzinga
No Merck's COVID-19 Pill - US Government Ceases Free Distribution
October 05, 2023
The U.S. government is set to cease the distribution of free doses of Merck & Co Inc's (NYSE: MRK) COVID-19 antiviral treatment Lagevrio (molnupiravir), by mid-November, shifting its availability to...
Via
Benzinga
Exposures
COVID-19
9 Analysts Have This to Say About Merck & Co
October 04, 2023
Via
Benzinga
Teva Pharma Hooks Sanofi In $1.5 Billion Inflammation Deal. But Shares Tumble.
October 04, 2023
The deal leans into the emerging TL1A drug class, potentially rivaling Roivant and Merck.
Via
Investor's Business Daily
Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares
October 04, 2023
3D Medicines Inc. was trading 7.2% higher in the Hong Kong Wednesday morning session at HK$5.53 after the company announced that it is buying back up to 10% of its own stock.
Via
Benzinga
How Is The Market Feeling About Merck & Co?
October 02, 2023
Via
Benzinga
3 Reasons to Buy Merck Stock
September 22, 2023
This list is by no means exhaustive.
Via
The Motley Fool
Check Out What Whales Are Doing With MRK
September 19, 2023
Via
Benzinga
2 Magnificent Growth Stocks to Buy Right Now
October 04, 2023
These two biotech stocks could be big winners for patient investors.
Via
The Motley Fool
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration
October 03, 2023
All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administration
Via
Benzinga
Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares
October 03, 2023
NY Mets owner billionaire Steve Cohen has bought as many as 119,092,680 ordinary shares of clinical-stage biopharmaceutical company Bionomics Limited (NASDAQ: BNOX) through his Point72 asset management...
Via
Benzinga
Why Cancer-Focused ALX Oncology Stock Gained Over 100% Today?
October 03, 2023
ALX Oncology Holdings Inc (NASDAQ: ALXO) released prespecified interim Phase 2 data from its ASPEN-06 trial of evorpacept plus trastuzumab, Cyramza (ramucirumab) and paclitaxel for HER2-positive...
Via
Benzinga
Why Shares of Iovance Biotherapeutics Jumped Monday
September 18, 2023
The company's stock rally began on Friday.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
October 02, 2023
Via
Benzinga
These Market Experts See a Downturn Coming: 2 Defensive Index Funds That Are Proven Moneymakers to Buy Now
October 01, 2023
These defensive index funds can help investors hedge against a possible recession.
Via
The Motley Fool
Here's Why You Should Consider Moderna Stock, and No, It's Not the COVID Vaccine
September 30, 2023
The COVID-19 vaccine put Moderna on the map, but its pipeline is going to be what keeps it there.
Via
The Motley Fool
Exposures
COVID-19
10 Health Care Stocks With Whale Alerts In Today's Session
September 29, 2023
Via
Benzinga
Amazon Web Services Now Offers Generative AI Tools For Businesses, Catches Up With Microsoft Azure, Google Cloud
September 28, 2023
Amazon is stepping into the generative AI arena with a new product called Bedrock, which offers its Amazon Web Services clients the use of generative AI tools.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Pharma Giants Shift Stance, Embrace Medicare Negotiations Amid Rising Drug Costs
September 28, 2023
AstraZeneca Plc (NASDAQ: AZN), Bristol Myers Squibb & Co (NYSE: BMY), and Boehringer Ingelheim are willing to participate in the initial round of Medicare drug price negotiation
Via
Benzinga
Mainz Biomed To Present The Power Of mRNA That Promises To Revolutionize Medicine
September 27, 2023
Pharma companies across the globe, including Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA), are harnessing the potential of mRNA which is creating plenty of space for scientific improvement in...
Via
Benzinga
With Cancer Immunotherapy Market Set To Grow At Double-Digit CAGR Till 2032, This Company Plans To Ride The Wave Through Treatments For Complex Cancers
September 25, 2023
Oncotelic Therapeutics Inc. (OTCQB: OTLC) is a clinical-stage biopharmaceutical company.
Via
Benzinga
Why Is Seagen Stock Trading Higher Today?
September 22, 2023
Seagen Inc (NASDAQ: SGEN) and Astellas Pharma Inc (OTC: ALPMF) (OTC:
Via
Benzinga
Merck-Eisai Partnered Two Keytruda/Lenvima Combo Trials Flunk In Certain Types Of Lung Cancer
September 22, 2023
Merck & Co Inc (NYSE: MRK) and Eisai Co Ltd (OTC: ESALY) (OTC:
Via
Benzinga
Seagen Pops After Scoring A 'Must-Win' For Its $43 Billion Takeover By Pfizer
September 22, 2023
The companies tested a key combination in patients with previously untreated bladder cancer.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
September 21, 2023
Via
Benzinga
Promising Preclinical Results From Blood Cancer Propel Oncternal To Buy Rating
September 18, 2023
HC Wainwright has upgraded Oncternal Therapeutics Inc (NASDAQ: ONCT) to Buy from Neutral with a
Via
Benzinga
Is This 250-Year-Old Japanese Big Pharma Giant Selling For Half Price Right Now?
September 18, 2023
When it comes to Big Pharma, Japan’s Takeda Pharmaceutical Co Ltd (NYSE: TAK) is a conservative play that could prove to be a big winner given its cheap valuation and suite of new drugs that portend to...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 14, 2023
Via
Benzinga
Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm
September 13, 2023
Moderna released encouraging results for its late-stage trial of its flu vaccine. Now, MRNA stock is looking like more than a one-trick pony.
Via
InvestorPlace
Mainz Biomed Paves The Way For Early Colorectal Cancer Diagnosis And Even Prevention
September 13, 2023
By the words of Dr. Ruediger Dahlke, cancer is a caricature of today’s modern society as it reflects the dark side ‘growth’. Our civilization is clearly more on the dark side of growth with technology...
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
64
65
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.